Business
InspireMD to Report Third Quarter 2021 Financial Results on November 9, 2021 and Provide Corporate Business Update
Earnings Conference Call to be held Tuesday, November 9, 2021, at 8:30 a.m. ET TEL AVIV, Israel, Oct. 26, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq:
About this update from Inspiremd Inc.
[{"type":"text","content":"Earnings Conference Call to be held Tuesday, November 9, 2021, at 8:30 a.m. ET\nTEL AVIV, Israel, Oct. 26, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces it will report third quarter 2021 financial results on Tuesday, November 9, 2021, before the market opens. Management will host a conference call and webcast with the investment community at 8:30 am (ET) that same day to review financial results and provide an update on corporate developments. Title:InspireMD Third Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast Date:Tuesday, November 9, 2021 Time:8:30 a.m. ET Conference Call Details:Toll-Free: 877-407-4018International: 201-689-8471Conference ID: 13724012 The conference call will be webcast live from the Company’s website and will be available via the following links: Webcast:Webcast Link - Click Herehttps://www.inspiremd.com/en/investors/investor-relations/ The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company’s website. About InspireMD, Inc. InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes. Forward-looking Statements This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. For example, the Company is using forward-looking statements when it discusses the number of expected patients to be enrolled in the trial, that the initiation of the trial marks an important milestone for the potential approval of the CGuard EPS and towards advancing the treatment of CAD and stroke prevention, and that the initiation of the trial marks the beginning of the next step in the Company’s journey towards CGuard EPS being utilized in the U.S. Forward-looking statements are not guarantees of future performance, are based on certain assum...